Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001255294-14-001282
Filing Date
2014-12-12
Accepted
2014-12-12 17:09:20
Documents
10
Period of Report
2014-10-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-Q 222423
2 EX31_1 ex31_1.htm EX-31.1 9238
3 EX31_2 ex31_2.htm EX-31.2 9196
4 EX32_1 ex32_1.htm EX-32.1 5248
  Complete submission text file 0001255294-14-001282.txt   1344732

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE atoa-20141031.xml EX-101.INS 76246
6 XBRL SCHEMA FILE atoa-20141031.xsd EX-101.SCH 14093
7 XBRL CALCULATION FILE atoa-20141031_cal.xml EX-101.CAL 20772
8 XBRL DEFINITION FILE atoa-20141031_def.xml EX-101.DEF 21373
9 XBRL LABEL FILE atoa-20141031_lab.xml EX-101.LAB 103392
10 XBRL PRESENTATION FILE atoa-20141031_pre.xml EX-101.PRE 84196
Mailing Address BIOCITY SCOTLAND, NEWHOUSE LANARKSHIRE X0 ML1 5UH
Business Address BIOCITY SCOTLAND, NEWHOUSE LANARKSHIRE X0 ML1 5UH 44 1698 53 9797
Altovida Inc. (Filer) CIK: 0001529293 (see all company filings)

EIN.: 452759045 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 333-176736 | Film No.: 141284340
SIC: 2834 Pharmaceutical Preparations